59 related articles for article (PubMed ID: 8855823)
1. A mechanism for the suppression of estrogen production in polycystic ovary syndrome.
Agarwal SK; Judd HL; Magoffin DA
J Clin Endocrinol Metab; 1996 Oct; 81(10):3686-91. PubMed ID: 8855823
[TBL] [Abstract][Full Text] [Related]
2. Luteolin and its analog luteolin-7-methylether from Leonurus japonicus Houtt suppress aromatase-mediated estrogen biosynthesis to alleviate polycystic ovary syndrome by the inhibition of tumor progression locus 2.
Shi XK; Peng T; Azimova B; Li XL; Li SS; Cao DY; Fu NJ; Zhang GL; Xiao WL; Wang F
J Ethnopharmacol; 2024 Sep; 331():118279. PubMed ID: 38705425
[TBL] [Abstract][Full Text] [Related]
3. Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway.
Rice S; Pellatt L; Ramanathan K; Whitehead SA; Mason HD
Endocrinology; 2009 Oct; 150(10):4794-801. PubMed ID: 19574398
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone Restores the Repressive Effect of Tumor Necrosis Factor-α on Follicular Growth and E
Wu Q; Zhuang T; Li Z
Reprod Sci; 2021 Nov; 28(11):3248-3257. PubMed ID: 33825169
[TBL] [Abstract][Full Text] [Related]
5. Klotho accelerates the progression of polycystic ovary syndrome through promoting granulosa cell apoptosis and inflammation.
Ye W; Xia S; Xie T; Ye H; Yang Y; Sun Y; Cai J; Luo X; Zhou L; Song Y
Biol Reprod; 2024 Jun; ():. PubMed ID: 38874314
[TBL] [Abstract][Full Text] [Related]
6. Metabolome implies increased fatty acid utilization and histone methylation in the follicles from hyperandrogenic PCOS women.
Xu Y; Zhou Z; Zhang G; Yang Z; Shi Y; Jiang Z; Liu Y; Chen H; Huang H; Zhang Y; Pan J
J Nutr Biochem; 2024 Mar; 125():109548. PubMed ID: 38104867
[TBL] [Abstract][Full Text] [Related]
7. The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date.
Kolnikaj TS; Herman R; Janež A; Jensterle M
Medicina (Kaunas); 2024 Jan; 60(2):. PubMed ID: 38399531
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of Human Estrogen Signaling as a Novel Molecular Signature of Polycystic Ovary Syndrome.
Marie C; Pierre A; Mayeur A; Giton F; Corre R; Grynberg M; Cohen-Tannoudji J; Guigon CJ; Chauvin S
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069013
[TBL] [Abstract][Full Text] [Related]
9. Suggesting disease associations for overlooked metabolites using literature from metabolic neighbors.
Delmas M; Filangi O; Duperier C; Paulhe N; Vinson F; Rodriguez-Mier P; Giacomoni F; Jourdan F; Frainay C
Gigascience; 2022 Dec; 12():. PubMed ID: 37712592
[TBL] [Abstract][Full Text] [Related]
10. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.
Fedeli V; Catizone A; Querqui A; Unfer V; Bizzarri M
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047265
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-acetylcysteine and metformin treatment on the stereopathological characteristics of uterus and ovary.
Rafiee B; Karbalay-Doust S; Tabei SMB; Azarpira N; Alaee S; Lohrasbi P; Bahmanpour S
Eur J Transl Myol; 2022 May; 32(2):. PubMed ID: 35535444
[TBL] [Abstract][Full Text] [Related]
12. Ovarian response to follicle-stimulating hormone in women with polycystic ovary syndrome is diminished compared to ovulatory controls.
Harrison TNH; Chang RJ
Clin Endocrinol (Oxf); 2022 Sep; 97(3):310-318. PubMed ID: 35244287
[TBL] [Abstract][Full Text] [Related]
13. Long-term Hyperandrogenemia and/or Western-style Diet in Rhesus Macaque Females Impairs Preimplantation Embryogenesis.
Ravisankar S; Murphy MJ; Redmayne-Titley N; Davis B; Luo F; Takahashi D; Hennebold JD; Chavez SL
Endocrinology; 2022 Apr; 163(4):. PubMed ID: 35192701
[TBL] [Abstract][Full Text] [Related]
14. Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies.
Chauvin S; Cohen-Tannoudji J; Guigon CJ
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008938
[TBL] [Abstract][Full Text] [Related]
15. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome.
Yu L; Liu M; Wang Z; Liu T; Liu S; Wang B; Pan B; Dong X; Guo W
Reprod Biol Endocrinol; 2021 May; 19(1):74. PubMed ID: 34001150
[TBL] [Abstract][Full Text] [Related]
16. Biological and Clinical Rationale for Androgen Priming in Ovarian Stimulation.
Løssl K; Freiesleben NC; Wissing ML; Birch Petersen K; Holt MD; Mamsen LS; Anderson RA; Andersen CY
Front Endocrinol (Lausanne); 2020; 11():627. PubMed ID: 33013703
[TBL] [Abstract][Full Text] [Related]
17. Depletion of exosomal circLDLR in follicle fluid derepresses miR-1294 function and inhibits estradiol production via CYP19A1 in polycystic ovary syndrome.
Huang X; Wu B; Chen M; Hong L; Kong P; Wei Z; Teng X
Aging (Albany NY); 2020 Jul; 12(15):15414-15435. PubMed ID: 32651991
[TBL] [Abstract][Full Text] [Related]
18. Role of epigenetic modifications in the aberrant
Hosseini E; Shahhoseini M; Afsharian P; Karimian L; Ashrafi M; Mehraein F; Afatoonian R
Arch Med Sci; 2019 Jul; 15(4):887-895. PubMed ID: 31360184
[TBL] [Abstract][Full Text] [Related]
19. Developmental programming by androgen affects the circadian timing system in female mice.
Mereness AL; Murphy ZC; Sellix MT
Biol Reprod; 2015 Apr; 92(4):88. PubMed ID: 25695720
[TBL] [Abstract][Full Text] [Related]
20. Direct actions of androgens on the survival, growth and secretion of steroids and anti-Müllerian hormone by individual macaque follicles during three-dimensional culture.
Rodrigues JK; Navarro PA; Zelinski MB; Stouffer RL; Xu J
Hum Reprod; 2015 Mar; 30(3):664-74. PubMed ID: 25567619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
